Shailesh Dadge

Mr. Shailesh Dadge

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SDShailesh Dadge
Shailesh Dadge
SASyed Anees Ahmed
Syed Anees Ahmed
AHAthar Husain
Athar Husain
GVGuru Raghavendra Valicherla
Guru Raghavendra Valicherla
JGJiaur R. Gayen
Jiaur R. Gayen
Cissus quadrangularis is a nutrient-rich plant with a history of use in traditional medicine. It boasts a diverse range of polyphenols, including quercetin, resveratrol, β-sitosterol, myricetin, and other compounds. We developed and validated a sensitive LC-MS/MS method to quantify quercetin and t-res biomarkers in rat serum and applied this method to pharmacokinetic and stability studies. The mass spectrometer was set to negative ionization mode for the quantification of quercetin and t-res. Phenomenex Luna (C18(2), 100 A, 75 × 4.6 mm, 3 µ) column was utilized to separate the analytes using an isocratic mobile phase consisting of methanol and 0.1% formic acid in water (82:18). Validation of the method was performed using various parameters, including linearity, specificity, accuracy, stability, intra-day, inter-day precision, and the matrix effect. There was no observed significant endogenous interference from the blank serum. The analysis was completed within 5.0 min for each run, and the lower limit of quantification was 5 ng/mL. The calibration curves showed a linear range with a high correlation coefficient (r2 > 0.99). The precision for intra- and inter-day assays showed relative standard deviations from 3.32% to 8.86% and 4.35% to 9.61%, respectively. The analytes in rat serum were stable during bench-top, freeze-thaw, and autosampler (−4 °C) stability studies. After oral administration, the analytes showed rapid absorption but underwent metabolism in rat liver microsomes despite being stable in simulated gastric and intestinal fluids. Intragastric administration resulted in higher absorption of quercetin and t-res, with greater Cmax, shorter half-life, and improved elimination. No prior research has been conducted on the oral pharmacokinetics and stability of anti-diabetic compounds in the Ethanolic extract of Cissus quadrangularis EECQ, making this the first report. Our findings can provide the knowledge of EECQ’s bioanalysis and pharmacokinetic properties which is useful for future clinical trials.

6 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
GVGuru Raghavendra Valicherla
Guru Raghavendra Valicherla
RKRoshan Katekar
Roshan Katekar
SDShailesh Dadge
Shailesh Dadge
Riyazuddin MohammedRiyazuddin Mohammed
Riyazuddin Mohammed
SASyed Anees Ahmed
Syed Anees Ahmed
JGJiaur R. Gayen
Jiaur R. Gayen
PSTi8 is a pancreastatin inhibitory peptide that is effective in the treatment of diabetic models. This study investigates the pharmacokinetic (PK) properties of PSTi8 in Sprague Dawley rats, for the first time. In vitro and in vivo PK studies were performed to evaluate the solubility, stability in plasma and liver microsomes, plasma protein binding, blood–plasma partitioning, bioavailability, dose proportionality, and gender difference in PK. Samples were analyzed using the validated LC-MS/MS method. The solubility of PSTi8 was found to be 9.30 and 25.75 mg/mL in simulated gastric and intestinal fluids, respectively. The protein binding of PSTi8 was estimated as >69% in rat plasma. PSTi8 showed high stability in rat plasma and liver microsomes and the blood–plasma partitioning was >2. The bioavailability of PSTi8 after intraperitoneal and subcutaneous administration was found to be 95.00 ± 12.15 and 78.47 ± 17.72%, respectively, in rats. PSTi8 showed non-linear PK in dose proportionality studies, and has no gender difference in the PK behavior in rats. The high bioavailability of PSTi8 can be due to high water solubility and plasma protein binding, low clearance and volume of distribution. Our in vitro and in vivo findings support the development of PSTi8 as an antidiabetic agent.

29 September 2025 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
SDShailesh Dadge
Shailesh Dadge
SMShivam Mishra
Shivam Mishra
SKSharib Khan
Sharib Khan
SYShubhi Yadav
Shubhi Yadav
RBRabi Sankar Bhatta
Rabi Sankar Bhatta
JGJiaur R. Gayen
Jiaur R. Gayen

5 September 2024 in Biomedical Chromatography
Verified
Journal Article
Closed access
SDShailesh Dadge
Shailesh Dadge
SYShubhi Yadav
Shubhi Yadav
SRShivam Rathaur
Shivam Rathaur
JGJiaur R. Gayen
Jiaur R. Gayen

12 November 2025 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
AAArun Agarwal
Arun Agarwal
SDShailesh Dadge
Shailesh Dadge
RGRicha Garg
Richa Garg
DCDivya Chauhan
Divya Chauhan
RKRoshan Katekar
Roshan Katekar
JGJiaur R. Gayen
Jiaur R. Gayen
Background: Formononetin (FNT), a phytoestrogen, has shown osteogenic effects in ovariectomy-induced osteoporosis, but its therapeutic use is limited by poor bioavailability. This study aimed to compare the osteogenic potential of pure FNT and formononetin–piperine–phospholipid complex (FNT-PIP-PC) in OVX-induced osteoporosis and to quantify free FNT concentration in rat bone marrow. An in vivo study was conducted using an OVX-induced osteoporosis rat model. Adult female Sprague–Dawley (SD) rats were ovariectomized and treated orally with FNT or FNT-PIP-PC at 5mg/kg for 12 weeks. Therapeutic efficacy was evaluated using body composition analysis, µCT, L5 compression, bone markers, and pharmacokinetics parameters in the bone marrow via LC–ESI–MS/MS. Results: FNT-PIP-PC treatment significantly restored trabecular bone volume and microarchitecture in the femur and tibia, improved uterine mass, increased osteocalcin (OCN), and reduced C-terminal telopeptide of type 1 collagen (CTX) levels. These findings aligned with enhanced mRNA expression of RUNX, RANKL, BMP2, and OPG. Additionally, FNT-PIP-PC improved pharmacokinetic parameters like C max , AUC 0-t , and AUC 0-∞ of free FNT from FNT-PIP-PC compared to pure FNT. Conclusion: Oral administration of FNT through complexation with PIP reduced phase II metabolism and enhanced free FNT concentrations, leading to a significant increase in its bioavailability in bone marrow, supporting the targeted delivery. Furthermore, the FNT-PIP-PC complex demonstrated a marked improvement in the osteogenic potential of FNT on OVX-induced osteoporosis rats with no significant adverse effects. Collectively, these findings support the FNT-PIP-PC potential as a safe and effective therapeutic option for postmenopausal osteoporosis. Graphic

30 October 2025 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
SYShubhi Yadav
Shubhi Yadav
SDShailesh Dadge
Shailesh Dadge
SRShivam Rathaur
Shivam Rathaur
DMDebalina Maity
Debalina Maity
VPV.M. Prajapati
V.M. Prajapati
JGJiaur R. Gayen
Jiaur R. Gayen